跳至主要内容
临床试验/JPRN-UMIN000052124
JPRN-UMIN000052124招募中Unknown

Cost-effectiveness analysis of systemic therapy for non-small cell lung cancer based on real-world data - Cost-effectiveness analysis of systemic therapy for non-small cell lung cancer based on real-world data

Showa University0 个研究点目标入组 100 人开始时间: 2023年9月5日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with the following driver gene mutations or translocations will be included: EGFR gene mutation ALK fusion gene ROS1 fusion gene BRAF gene mutation MET gene mutation RET fusion gene NTRK fusion gene In the future, if new primary standard treatments are identified for additional driver gene mutations or translocations, patients with those newly identified driver gene mutations or translocations will also be excluded from the study.

研究者

相似试验